The University of Louisville has received $11.6 million from the National Institutes of Health to research how diabetes causes heart disease and how to prevent that from happening.
The university will establish a Center of Excellence in Diabetes and Obesity Research with the five-year grant, using the money to hire researchers, buy equipment and renovate part of a research building.
The agency awarded a similar grant yesterday to the University of Kentucky -- $10.53... read more
Submitted by Avera
Hundreds of Australians with Type 1 diabetes are trying to join a clinical trial in New Zealand which will see human patients injected with pig cells.
The New Zealand Government has given the trial the green light despite fears about the spread of pig viruses and disease.
A similar trial can't be carried out here in Australia, because for the past three years a moratorium has been in place on Xenotransplantation which is the use... read more
Submitted by Avera
A respected Queensland University of Technology researcher and his team have received $5 million from the Juvenile Diabetes Foundation International, the third-biggest grant they have ever given to an Australian research team.
Professor Nathan Efron of QUT's Institute of Health and Biomedical Innovation is the principal researcher of the five year study, which will test the efficacy of detecting the progress of diabetic neuropathy by looking at the nerves in the cornea, at the... read more
Submitted by Avera
A molecule called interleukin-6 has opened new doors for the creation of new drugs against obesity and diabetes. These are the conclusions of an international project which has had the participation of researchers from Vitagenes, a company which forms part of the Campus program promoted by the University of Granada (UGR) and situated in the Technological Park of Health Sciences (PTS).
Submitted by Avera
ScienceDaily (Oct. 17, 2008) — A molecule called interleukin-6 has opened new doors for the creation of new drugs against obesity and diabetes.
This is the conclusion of an international project which has had the participation of researchers from Vitagenes, a company which forms part of the Campus program promoted by the University of Granada (UGR) and situated in the Technological Park of Health Sciences (PTS).
Submitted by Avera
Oct. 17 (Bloomberg) -- Boehringer Ingelheim GmbH, the world's largest family-owned pharmaceutical company, is conducting trials of three Type 2 diabetes medicines designed to be taken by mouth.
Boehringer is running the last of three stages of tests required for regulatory approval on a DPP-4 inhibitor shown to lower blood sugar without causing hypoglycemic episodes or weight gain, the company said today in a press conference at its research facility in Biberach, Germany. Boehringer... read more
Submitted by Avera
ScienceDaily (Oct. 15, 2008) — A protein made by the liver in response to inflammation and used to treat patients suffering from a genetic form of emphysema has been shown to restore blood glucose levels in a mouse model of Type 1 diabetes mellitus, according to a new study led by researchers at Beth Israel Deaconess Medical Center (BIDMC).
Submitted by Avera
Wright and his lab have discovered that PTF1A is crucial to the formation of the pancreas, including the beta cells that produce the insulin that diabetics lack. "Take away PTF1A, and cells can no longer form the pancreas . . . . They change their job," Wright says.
Submitted by Avera
NEW YORK (Reuters Health) - Drinking moderate amounts of alcohol may protect women from developing type 2 diabetes, but the effect of alcohol on inflammation and blood vessel function doesn't appear to explain the relationship, new research suggests.
Dr. Joline W. J. Beulens of University Medical Center Utrecht, The Netherlands, and colleagues found that adiponectin -- a hormone secreted by fatty tissue that regulates how the body uses fat and glucose (sugar) -- accounted for... read more
Submitted by Avera
The painkiller pentazocine may help prevent diabetes-related retinal damage that leads to vision loss, according to Medical College of Georgia researchers.
Submitted by CMeli1027